Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPennon Regulatory News (PNN)

Share Price Information for Pennon (PNN)

Share Price is delayed by 15 minutes
Get Live Data
461.00    1.40 (0.30%)
Bid:
460.60
Ask:
461.00
Spread: 0.40 (0.087%)
Market Cap: £2.17b
PNN Live PriceLast checked at - London Stock Exchange

Intraday Pennon Share Chart

Pennon Peninsula MB Unwind

9 Feb 2017 07:13

RNS Number : 4224W
Pennon Group PLC
09 February 2017
 

9 February 2017

 

PENNON GROUP PLC

 

2011 Peninsula MB derivative unwind following agreement with Nomura

 

Pennon Group Plc ("Pennon" or the "Group") today announces that it has agreed terms with Nomura to unwind a derivative, entered into in 2011, through Peninsula MB Ltd. The derivative had been due to end in 2027, however, following a change in the economic benefit of this derivative outlined in the half year results 2016/17, Pennon is exercising its option to unwind the transaction early.

 

The process for unwinding the derivative means that Pennon is acquiring a financial asset with a value of £283 million and a financial liability with a value of £239 million from Nomura Structured Holdings plc. The counter-party to both these transactions is Peninsula MB Ltd.

 

Simultaneously, Pennon will also acquire the remaining 25% of Peninsula MB Ltd's share capital from Nomura Structured Holdings plc with all Peninsula MB Ltd's liabilities now due to Pennon. Pennon is settling these liabilities through inter-company transactions with Peninsula MB Ltd. It is Pennon's intention to cease any future operating activities of Peninsula MB Ltd at this point and liquidate the company in due course.

 

The net consideration due to Nomura Structured Holdings plc in respect of these transactions is £44 million with an agreed payment date of June 2018. The impact for Pennon is expected to be a net cost of £35 million post-tax. The estimated overall post-tax impact of these transactions has already been reflected through the £39.5 million derivative liability recognised in the half year results 2016/17.

 

Peninsula MB Ltd

 

Peninsula MB Ltd is a private limited company, incorporated in England and Wales on 5 December 2011 as a subsidiary of Nomura Structured Holdings plc, part of the "Nomura Group". Prior to the transaction announced today, Peninsula MB Ltd's share capital was 75%-owned by Pennon and 25%-owned by Nomura Structured Holdings Plc, who had control of the company for accounting purposes. The principal activity of Peninsula MB Ltd was raising funds through the issuance of debt instruments and third party lending. As of the date of this announcement, Peninsula MB Ltd's only debt instruments and third party lending were as follows:

 

I. A £200 million floating interest rate-linked loan from Peninsula MB Ltd to Pennon.

II. A corresponding fixed rate £200 million loan from Pennon to Peninsula MB Ltd.

In combination, I and II were treated as a derivative targeted at providing a return to Pennon, linked to a Nomura index. It was designed to improve Pennon's overall interest rate performance (c.£8 million p.a. benefit, cash settled). On unwinding this derivative, I and II will offset each other, leaving no balances outstanding and Pennon will no longer receive the c.£8 million p.a. interest rate benefit.

 

III. A £200 million floating interest rate-linked loan from Nomura Structured Holdings plc to Peninsula MB Ltd.

IV. A fixed rate £200 million loan from Peninsula MB Ltd to Nomura Structured Holdings plc.

On Pennon acquiring III and IV from Nomura Structured Holdings plc and the remaining 25% of Peninsula MB Ltd's share capital, III and IV will be settled through inter-company transactions between Pennon and Peninsula MB Ltd, leaving no balances outstanding.

 

In aggregate the acquisition of Peninsula MB Ltd concerns total gross assets of £201 million and net liabilities of £246 million as at 31st March 2016.

 

 

 

For further information, please contact:

Pennon: Susan Davy - Chief Financial Officer Sarah Heald - Director of Corporate Affairs & Investor Relations 01392 443 401

Finsbury: James Murgatroyd Faeth Birch 0207 251 3801

Cautionary statement in respect of forward-looking statements

 

Certain statements in this announcement are forward-looking statements relating to the Group's operations, performance and financial position based on current expectations of, and assumptions and forecasts made by, management. They are subject to a number of risks, uncertainties and other factors that could cause actual results, performance or achievements of the Group to differ materially from any outcomes or results expressed or implied by such forward-looking statements. The Group's principal risks were described in the 2016 Pennon Group Annual Report which can be viewed online at http://www.pennonannualreport.co.uk/2016/. Such forward looking statements should therefore be construed in light of such risks, uncertainties and other factors and undue reliance should not be placed on them. They are made only as of the date of this announcement and no representation, assurance, guarantee or warranty is given in relation to them including as to their accuracy, completeness, or the basis on which they are made. No obligation is accepted to publicly revise or update these forward-looking statements or adjust them as a result of new information or for future events or developments, except to the extent legally required. Nothing in this Statement should be construed as a profit forecast.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCOKCDKOBKKDBK
Date   Source Headline
22nd Jun 202610:55 amRNSDirector/PDMR Shareholding
18th Jun 20262:53 pmRNSEMTN: Publication of Supplementary Prospectus
16th Jun 20267:00 amRNSPublication of Annual Report and Accounts 2026
10th Jun 20267:00 amRNSFull Year Results 2025/26
1st Jun 20267:00 amRNSTotal Voting Rights
29th May 20262:06 pmRNSHolding(s) in Company
20th May 20261:48 pmRNSDirector/PDMR Shareholding
14th May 202612:03 pmRNSDirector/PDMR Shareholding
6th May 20262:12 pmRNSAdmission to Trading
1st May 20264:31 pmRNSHolding(s) in Company
1st May 20267:00 amRNSTotal Voting Rights
30th Apr 20263:11 pmRNSHolding(s) in Company
27th Apr 20264:34 pmRNSHolding(s) in Company
24th Apr 20263:29 pmRNSHolding(s) in Company
22nd Apr 20264:30 pmRNSHolding(s) in Company
21st Apr 20261:17 pmRNSDirector/PDMR Shareholding
20th Apr 20264:09 pmRNSHolding(s) in Company
14th Apr 20264:24 pmRNSRescheduled Full-Year Results Date
1st Apr 20267:00 amRNSTotal Voting Rights
20th Mar 20262:06 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNSTrading Statement
2nd Mar 20267:00 amRNSTotal Voting Rights
23rd Feb 202612:58 pmRNSDirector/PDMR Shareholding
10th Feb 20267:00 amRNSConfirmation of Chief Executive Officer Start Date
5th Feb 202610:58 amRNSHolding(s) in Company
2nd Feb 20267:01 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSBlock listing Interim Review
23rd Jan 20263:21 pmRNSDirector/PDMR Shareholding
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
23rd Dec 20253:29 pmRNSDirector/PDMR Shareholding
23rd Dec 20253:29 pmRNSDirector/PDMR Shareholding
11th Dec 20251:16 pmRNSConfirmed Financial Calendar
9th Dec 20254:01 pmRNSDirector/PDMR Shareholding
9th Dec 20257:00 amRNSPennon Group CEO Transition Arrangements
1st Dec 20253:42 pmRNSEMTN: Publication of Supplementary Prospectus
1st Dec 20257:00 amRNSTotal Voting Rights
27th Nov 20257:00 amRNSHalf Year Results 2025/26
21st Nov 20254:24 pmRNSDirector/PDMR Shareholding
3rd Nov 20257:00 amRNSTotal Voting Rights
22nd Oct 20251:26 pmRNSDirector/PDMR Shareholding
7th Oct 20257:00 amRNSPennon appoints new Non-Executive Director
3rd Oct 20252:19 pmRNSDirector/PDMR Shareholding
2nd Oct 20257:00 amRNSPennon Group appoints Keith Haslett as new CEO
1st Oct 20257:00 amRNSTotal Voting Rights
26th Sep 20257:00 amRNSTrading Statement
23rd Sep 20254:16 pmRNSDirector/PDMR Shareholding
11th Sep 202512:09 pmRNSEMTN Programme: Publication of Final Terms
1st Sep 20257:00 amRNSTotal Voting Rights
28th Aug 20252:44 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.